You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 11, NOVEMBER 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Painful Diabetic Neuropathy With Topical Capsaicin

A Multicenter, Double-blind, Vehicle-Controlled Study

The Capsaicin Study Group

Arch Intern Med. 1991;151(11):2225-2229.


Abstract

A multicenter study was conducted to establish the efficacy of topical 0.075% capsaicin cream in relieving the pain associated with diabetic neuropathy. Capsaicin or vehicle cream was applied to painful areas four times per day for 8 weeks in patients randomly assigned to one of two groups. Pain intensity and relief were recorded at 2-week intervals using physician's global evaluation and visual analog scales. Analysis at final visit for 252 patients showed statistical significance favoring capsaicin compared with vehicle for the following: 69.5% vs 53.4% pain improvement by the physician's global evaluation scale, 38.1% vs 27.4% decrease in pain intensity, and 58.4% vs 45.3% improvement in pain relief. With the exception of transient burning, sneezing, and coughing, capsaicin was well tolerated. Study results suggest that topical capsaicin cream is safe and effective in treating painful diabetic neuropathy.

(Arch Intern Med. 1991;151:2225-2229)



Footnotes

Accepted for publication May 8, 1991.

Presented in part at the 42nd Annual Meeting of the American Academy of Neurology, Miami, Fla, May 4, 1990.

Reprint requests to Department of Neurology, Bowman Gray School of Medicine, Wake Forest University, Medical Center Boulevard, Winston-Salem, NC 27157-1078 (Peter D. Donofrio, MD).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Painful Diabetic Peripheral Neuropathy
Smith
J. Am. Podiatr. Med. Assoc. 2007;97:394-401.
ABSTRACT | FULL TEXT  

Pain Management in Elderly Patients
Hix
Journal of Pharmacy Practice 2007;20:49-63.
ABSTRACT  

Pharmacologic Treatments for Pain Associated With Diabetic Peripheral Neuropathies
Abrams
Journal of Pharmacy Practice 2007;20:103-109.
ABSTRACT  

Painful Diabetic Neuropathy: A Management-Centered Review
Huizinga and Peltier
Clin. Diabetes 2007;25:6-15.
ABSTRACT | FULL TEXT  

Final Report on the Safety Assessment of Capsicum Annuum Extract, Capsicum Annuum Fruit Extract, Capsicum Annuum Resin, Capsicum Annuum Fruit Powder, Capsicum Frutescens Fruit, Capsicum Frutescens Fruit Extract, Capsicum Frutescens Resin, and Capsaicin
International Journal of Toxicology 2007;26:3-106.
ABSTRACT | FULL TEXT  

Consensus Guidelines: Treatment Planning and Options
Argoff et al.
Mayo Clin Proc. 2006;81:S12-S25.
ABSTRACT | FULL TEXT  

Systematic review of topical capsaicin for the treatment of chronic pain
Mason et al.
BMJ 2004;328:991.
ABSTRACT | FULL TEXT  

Low-Intensity Laser Therapy for Painful Symptoms of Diabetic Sensorimotor Polyneuropathy: A controlled trial
Zinman et al.
Diabetes Care 2004;27:921-924.
ABSTRACT | FULL TEXT  

Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice
Rashid et al.
J. Pharmacol. Exp. Ther. 2003;306:709-717.
ABSTRACT | FULL TEXT  

Painful Sensory Neuropathy
Mendell and Sahenk
NEJM 2003;348:1243-1255.
FULL TEXT  

Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel et al.
Neurology 2003;60:927-934.
ABSTRACT | FULL TEXT  

Novel Expression of Vanilloid Receptor 1 on Capsaicin-Insensitive Fibers Accounts for the Analgesic Effect of Capsaicin Cream in Neuropathic Pain
Rashid et al.
J. Pharmacol. Exp. Ther. 2003;304:940-948.
ABSTRACT | FULL TEXT  

Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy
Halat and Dennehy
J Am Board Fam Med 2003;16:47-57.
ABSTRACT | FULL TEXT  

Complex regional pain syndrome
Harden
Br J Anaesth 2001;87:99-106.
ABSTRACT | FULL TEXT  

Pharmacologic treatment of pain in polyneuropathy
Sindrup and Jensen
Neurology 2000;55:915-920.
ABSTRACT | FULL TEXT  

Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain
Morello et al.
Arch Intern Med 1999;159:1931-1937.
ABSTRACT | FULL TEXT  

Vanilloid (Capsaicin) Receptors and Mechanisms
Szallasi and Blumberg
Pharmacol. Rev. 1999;51:159-212.
ABSTRACT | FULL TEXT  

Capsaicin Binds to the Intracellular Domain of the Capsaicin-Activated Ion Channel
Jung et al.
J. Neurosci. 1999;19:529-538.
ABSTRACT | FULL TEXT  

Recent advances: Control of chronic pain
Nurmikko et al.
BMJ 1998;317:1438-1441.
FULL TEXT  

Intradermal Injection of Capsaicin in Humans Produces Degeneration and Subsequent Reinnervation of Epidermal Nerve Fibers: Correlation with Sensory Function
Simone et al.
J. Neurosci. 1998;18:8947-8959.
ABSTRACT | FULL TEXT  

Herbal Remedies in Psychiatric Practice
Wong et al.
Arch Gen Psychiatry 1998;55:1033-1044.
ABSTRACT | FULL TEXT  

Long-Term Complications of Diabetes Mellitus
Nathan
NEJM 1993;328:1676-1685.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.